AI assistant
Barclays PLC — Major Shareholding Notification 2023
Dec 27, 2023
5250_mrq_2023-12-27_aad9b70f-2dea-4cec-85d3-667e87b9239d.html
Major Shareholding Notification
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 9560X
Barclays PLC
27 December 2023
| FORM 8.3 | |||||||
| PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY | |||||||
| A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR | |||||||
| MORE | |||||||
| Rule 8.3 of the Takeover Code (the "Code") | |||||||
| 1. | KEY INFORMATION | ||||||
| (a) | Full name of discloser: | Barclays PLC. | |||||
| (b) | Owner or controller of interest and short | ||||||
| positions disclosed, if different from 1(a): | |||||||
| (c) | Name of offeror/offeree in relation to whose | DECHRA PHARMACEUTICALS PLC | |||||
| relevant securities this form relates: | |||||||
| (d) | If an exempt fund manager connected with an | ||||||
| offeror/offeree, state this and specify identity of | |||||||
| offeror/offeree: | |||||||
| (e) | Date position held/dealing undertaken: | 22 Dec 2023 | |||||
| (f) | In addition to the company in 1(c) above, is the discloser making | NO | |||||
| disclosures in respect of any other party to the offer? | |||||||
| 2. | POSITIONS OF THE PERSON MAKING THE DISCLOSURE | ||||||
| (a) | Interests and short positions in the relevant securities of the offeror or offeree | ||||||
| to which the disclosure relates following the dealing(if any) | |||||||
| Class of relevant security: | 1p ordinary | ||||||
| Interests | Short Positions | ||||||
| Number | (%) | Number | (%) | ||||
| (1) | Relevant securities owned | ||||||
| and/or controlled: | 8,251,180 | 7.24% | 850,970 | 0.75% | |||
| (2) | Cash-settled derivatives: | ||||||
| and/or controlled: | 847,673 | 0.74% | 8,181,489 | 7.18% | |||
| (3) | Stock-settled derivatives (including options) | ||||||
| and agreements to purchase/sell: | 0 | 0.00% | 0 | 0.00% | |||
| TOTAL: | 9,098,853 | 7.99% | 9,032,459 | 7.93% | |||
| (b) | Rights to subscribe for new securities (including directors and other executive | ||||||
| options) | |||||||
| Class of relevant security in relation to | |||||||
| which subscription right exists | |||||||
| Details, including nature of the rights | |||||||
| concerned and relevant percentages: | |||||||
| 3. | DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER | ||||||
| (a) | Purchases and sales | ||||||
| Class of relevant | Purchase/sale | Number of | Price per unit | ||||
| security | securities | ||||||
| 1p ordinary | Purchase | 1,708,730 | 38.4209 GBP | ||||
| 1p ordinary | Purchase | 300,000 | 38.4715 GBP | ||||
| 1p ordinary | Purchase | 14,254 | 38.5211 GBP | ||||
| 1p ordinary | Purchase | 9,864 | 38.5043 GBP | ||||
| 1p ordinary | Purchase | 9,633 | 38.5196 GBP | ||||
| 1p ordinary | Purchase | 6,993 | 38.5400 GBP | ||||
| 1p ordinary | Purchase | 5,640 | 38.5993 GBP | ||||
| 1p ordinary | Purchase | 5,627 | 38.5593 GBP | ||||
| 1p ordinary | Purchase | 4,362 | 38.5012 GBP | ||||
| 1p ordinary | Purchase | 2,295 | 38.4851 GBP | ||||
| 1p ordinary | Purchase | 2,242 | 38.5200 GBP | ||||
| 1p ordinary | Purchase | 1,258 | 38.6000 GBP | ||||
| 1p ordinary | Purchase | 382 | 38.4600 GBP | ||||
| 1p ordinary | Purchase | 143 | 38.5272 GBP | ||||
| 1p ordinary | Purchase | 4 | 38.5800 GBP | ||||
| 1p ordinary | Purchase | 4 | 38.5600 GBP | ||||
| 1p ordinary | Sale | 75,000 | 38.5607 GBP | ||||
| 1p ordinary | Sale | 6,085 | 38.4200 GBP | ||||
| 1p ordinary | Sale | 2,153 | 38.4955 GBP | ||||
| 1p ordinary | Sale | 1,514 | 38.5200 GBP | ||||
| 1p ordinary | Sale | 1,188 | 38.6000 GBP | ||||
| 1p ordinary | Sale | 1,180 | 38.4979 GBP | ||||
| 1p ordinary | Sale | 266 | 38.4400 GBP | ||||
| 1p ordinary | Sale | 100 | 38.4600 GBP | ||||
| 1p ordinary | Sale | 81 | 38.5000 GBP | ||||
| 1p ordinary | Sale | 31 | 38.5219 GBP | ||||
| 1p ordinary | Sale | 1 | 38.5161 GBP | ||||
| (b) | Cash-settled derivative transactions | ||||||
| Class of | Product | Nature of dealing | Number of | Price per | |||
| relevant | description | reference | unit | ||||
| security | securities | ||||||
| 1p ordinary | SWAP | Closing Short | 940 | 38.4866 GBP | |||
| 1p ordinary | SWAP | Decreasing Long | 7,238 | 38.5100 GBP | |||
| 1p ordinary | SWAP | Decreasing Short | 1 | 38.5161 GBP | |||
| 1p ordinary | SWAP | Decreasing Short | 266 | 38.4400 GBP | |||
| 1p ordinary | SWAP | Decreasing Short | 730 | 38.4877 GBP | |||
| 1p ordinary | SWAP | Decreasing Short | 1,844 | 38.5013 GBP | |||
| 1p ordinary | SWAP | Decreasing Short | 6,085 | 38.4200 GBP | |||
| 1p ordinary | SWAP | Decreasing Short | 75,000 | 38.5607 GBP | |||
| 1p ordinary | CFD | Increasing Short | 183 | 38.5256 GBP | |||
| 1p ordinary | SWAP | Increasing Short | 382 | 38.4600 GBP | |||
| 1p ordinary | SWAP | Increasing Short | 595 | 38.4200 GBP | |||
| 1p ordinary | SWAP | Increasing Short | 605 | 38.5540 GBP | |||
| 1p ordinary | CFD | Increasing Short | 1,188 | 38.6000 GBP | |||
| 1p ordinary | CFD | Increasing Short | 5,627 | 38.5592 GBP | |||
| 1p ordinary | CFD | Increasing Short | 5,640 | 38.5992 GBP | |||
| 1p ordinary | SWAP | Increasing Short | 6,965 | 38.4776 GBP | |||
| 1p ordinary | SWAP | Increasing Short | 7,185 | 38.5433 GBP | |||
| 1p ordinary | SWAP | Increasing Short | 9,633 | 38.5196 GBP | |||
| 1p ordinary | SWAP | Increasing Short | 14,254 | 38.5211 GBP | |||
| 1p ordinary | SWAP | Opening Short | 17 | 38.5452 GBP | |||
| (c) | Stock-settled derivative transactions (including options) | ||||||
| (i) | Writing, selling, purchasing or varying | ||||||
| Class | Product | Writing, | Number | Exercise | Type | Expiry | Option |
| of | description | purchasing, | of | price | date | money | |
| relevant | selling, | securities | per unit | paid/ | |||
| security | varying etc | to which | received | ||||
| option | per unit | ||||||
| relates | |||||||
| (ii) | Exercising | ||||||
| Class of relevant | Product description | Exercising/ exercised against | Number of | Exercise price per | |||
| security | securities | unit | |||||
| (d) | Other dealings (including subscribing for new securities) | ||||||
| Class of relevant | Nature of Dealings | Details | Price per unit (if | ||||
| security | applicable) | ||||||
| 4. | OTHER INFORMATION | ||||||
| (a) | Indemnity and other dealings arrangements | ||||||
| Details of any indemnity or option arrangement, or any agreement or understanding, | |||||||
| formal or informal, relating to relevant securities which may be an inducement to deal | |||||||
| or refrain from dealing entered into by the exempt principal trader making the disclosure and any party | |||||||
| to the offer or any person acting in concert with a party to the offer: | |||||||
| NONE | |||||||
| (b) | Agreements, arrangements or understandings relating to options or derivatives | ||||||
| Details of any agreement, arrangement or understanding, formal or informal, between | |||||||
| the person making the disclosure and any other person relating to: | |||||||
| (i) the voting rights of any relevant securities under any option; or | |||||||
| (ii) the voting rights of future acquisition or disposal of any relevant securities to which | |||||||
| any derivative is referenced: | |||||||
| NONE | |||||||
| (c) | Attachments | ||||||
| Is a Supplemental Form 8 (Open Positions) attached? | NO | ||||||
| Date of disclosure: | 27 Dec 2023 | ||||||
| Contact name: | Large Holdings Regulatory Operations | ||||||
| Telephone number: | 020 3134 7213 | ||||||
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RETEAAAXAFLDFFA